DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics today announced the presentation of data on the immunosuppressive properties of its soluble CD83 (sCD83) protein at the 2008 Annual Scientific Meeting of the Canadian Society of Transplantation, held February 28 - March 2 in Mont-Tremblant, Quebec. The presentation, which will be made on February 29 by Argos’ collaborating scientists at the University of Western Ontario, will review data demonstrating that sCD83-treated dendritic cells from non-human primates are able to induce regulatory T cells in vitro.
